All posts by: Michael Zand

Global Mesenchymal Stem Cells Markets 2018: Advances & Applications – Presents Trend Rate Data for the MSC … – GlobeNewswire (press release)

Global Mesenchymal Stem Cells Markets 2018: Advances & Applications – Presents Trend Rate Data for the MSC …GlobeNewswire (press release)Mesenchymal Stem Cells (MSCs) are multipotent cells that can differentiate into a variety of cell types, incl… Continue reading

uniQure Gets Orphan Medicinal Product Designation for Huntington’s Gene Therapy – Labiotech.eu (blog)

Chinese scientists used Crispr gene editing on 86 human patients – Quartz

QuartzChinese scientists used Crispr gene editing on 86 human patientsQuartzScientists have genetically engineered the cells of at least 86 cancer and HIV patients in the country using Crispr-Cas9 technology since 2015, the Wall Street Journal reports … Continue reading

Global T-Cell Immunotherapy Market for Cancer & Pipeline Analysis 2018-2025 & 2030 – ResearchAndMarkets.com – Business Wire (press release)

Global T-Cell Immunotherapy Market for Cancer & Pipeline Analysis 2018-2025 & 2030 – ResearchAndMarkets.comBusiness Wire (press release)The report provides an in-depth study on the current state of the T-Cell Immunotherapy industry. Recently, t… Continue reading

Chinese scientists devise a nanoparticle based vehicle – BSA bureau (press release)

Chinese scientists devise a nanoparticle based vehicleBSA bureau (press release)A team of scientists from National Center for NanoScience and Technology, Beijing, China, in cooperation with medical scientists in Japan and China, have developed a gold-n… Continue reading

Metastatic Melanoma Patients May Benefit From Beta Blockers – Cancer Network

Metastatic Melanoma Patients May Benefit From Beta BlockersCancer NetworkBeta blockers appear to affect immune cells and improve immune function, and now investigators are reporting that beta blockers may play an important role in boosting immunotherap… Continue reading